Cargando…
Structure-Based Virtual Screening and De Novo Design to Identify Submicromolar Inhibitors of G2019S Mutant of Leucine-Rich Repeat Kinase 2
Missense mutations of leucine-rich repeat kinase 2 (LRRK2), including the G2019S mutant, are responsible for the pathogenesis of Parkinson’s disease. In this work, structure-based virtual screening of a large chemical library was carried out to identify a number of novel inhibitors of the G2019S mut...
Autores principales: | Park, Hwangseo, Kim, Taeho, Kim, Kewon, Jang, Ahyoung, Hong, Sungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654793/ https://www.ncbi.nlm.nih.gov/pubmed/36361616 http://dx.doi.org/10.3390/ijms232112825 |
Ejemplares similares
-
Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products
por: Park, Hwangseo, et al.
Publicado: (2021) -
Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer
por: Park, Hwangseo, et al.
Publicado: (2020) -
Leucine Rich Repeat Kinase 2 and Innate Immunity
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2020) -
Leucine-rich repeat kinase 2 at a glance
por: Zhu, Christiane, et al.
Publicado: (2023) -
An extracellular network of Arabidopsis leucine-rich repeat receptor kinases
por: Smakowska-Luzan, Elwira, et al.
Publicado: (2018)